DNASE1L3 and cervical cancer: Considering that there is a significant downregulation of motifs starting with “C” in non‐responders (Figure 7a), we further explored the expression of DNASE1L3 in cervical cancer and its impact on chemotherapy sensitivity and tumor progression.